GenoPalate Unveils Major Upgrade with Enhanced Food Index – Revolutionizing Personalized Nutrition
MILWAUKEE, Oct. 3, 2024 /PRNewswire/ -- GenoPalate, the leading US genomic nutrition platform, announces the launch of its significantly upgraded...
DNA
LenioBio Collaborates with ReciBioPharm to Scale Up ALiCE® Technology and Expedite Vaccine Production
Advancing CEPI's 100 Days Mission to Accelerate Vaccine Development DUSSELDORF, Germany, Oct. 2, 2024 /PRNewswire/ -- LenioBio, the leader in rapid...
Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative Combinations
NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- via InvestorWire — Annovis Bio Inc. (NYSE: ANVS) today announces its placement...
Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma
First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies...
Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
- ATH434 shows promise as a disease-modifying therapy for MSA - - ATH434-202 Phase 2 interim data demonstrate stabilization of...
Curve Therapeutics further strengthens leadership team with the appointment of Andre Hoekema as new Chair of Board
Dr Hoekema brings over four decades of successful biotech and life science leadershipDr Cora Griffin appointed to head up business...
Transmission Electron Microscope Market to Grow by USD 528.8 Million (2024-2028), Driven by Nanotechnology Focus, AI-Powered Market Evolution Report – Technavio
NEW YORK, Oct. 1, 2024 /PRNewswire/ -- Report on how AI is driving market transformation- The global transmission electron microscope market...
Air Doctor Raises $20 million Series B Round to Pioneer State-of-the-Art Digital Platform for Accessible Medical Care Abroad
Air Doctor connects travelers to a global network of over 20,000 multilingual doctors and specialists. The user-friendly app and cutting-edge...
Helix and WakeMed to Launch Major Genetic Health Initiative in Wake County
4-year population health program to improve preventive care and provide greater precision care SAN MATEO, Calif., and RALEIGH, N.C., Oct. 1,...
OccuPro Launches POET 4.0: Revolutionary Upgrade to Post Offer Employment Testing Software
KENOSHA, WI / ACCESSWIRE / October 1, 2024 / OccuPro, a leader in employment testing software, proudly announces the release...
Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025
BERKELEY, Calif. and MAINZ, Germany, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),...
Alignment Health Plan Introduces 2025 Medicare Advantage Plans to Address Diverse Care Needs of Seniors, from Cost Concerns to Chronic Conditions
Medicare beneficiaries encouraged to evaluate their plan benefits during annual enrollment period, Oct. 15-Dec. 7ORANGE, Calif., Oct. 01, 2024 (GLOBE...
Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society
CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing...
NUS researchers develop revolutionary technology to unravel complex protein interactions that could transform cancer diagnostics
Scalable and adaptable, TETRIS captures the diversity of protein interactions on site to inform accurate cancer diagnoses, enabling the personalisation...
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary...
TALVEY®▼ (talquetamab) and DARZALEX® (daratumumab) subcutaneous (SC) formulation-based combination shows deep and durable responses in patients with relapsed or refractory multiple myeloma
Updated data show 100 percent overall response rate, with 56 percent of patients achieving complete response or better with weekly...
Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday
Interview to Air Sunday, September 29, 2024 at 5:30 PM EST on Fox Business NetworkMIAMI, FL / ACCESSWIRE / September...
Reveal MRI Launches the Reveal Total Scan: A Breakthrough in Preventative Health Screening
HENDERSON, NV / ACCESSWIRE / September 26, 2024 / In early 2024, Reveal MRI (www.revealmri.com) introduced an innovative full-body MRI...
Allogene Therapeutics to Present Pre-Clinical Data Highlighting the Potential of ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Diseases, at the American College of Rheumatology (ACR) Convergence
The CD19/CD70 Dual CAR is Specifically Designed to Address Both the B-cell and T-cell Dysfunction Implicated in Autoimmune DiseasesALLO-329, is...
Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts
GAITHERSBURG, Md., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent”) today announced that two contract options have...